PMS-Duloxetine 30 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)

Affected lot exceeds the interim acceptable intake limit for N -nitroso-duloxetine (NDLX).

Product quality

Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.

PMS-Duloxetine 30 mg

RA-75397